Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update

NEXT STORY
Immunofluorescence Assay Market by Product, Type, Disease, End-user and Region – Global Forecast to 2026
PREV STORY
Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunotech Laboratories, Inc. Enters Negotiations to Engage a Quality Person (QP) for Receipt and Distribution of Treatment in Europe

MONROVIA, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. (OTC Markets "ECPO", ...

author_avatar
NASDAQ Market News

ZIOPHARM Oncology Reports Third Quarter 2017 Financial Results and Provides Update on Recent Activities

Company to host conference call today at 4:30 p.m. ETPivotal, randomized control trial in ...

author_avatar
NASDAQ Market News

$165.31 Billion Implantable Biomaterials Market Material, Application Analysis & Trends 2016 – Forecast to 2025

Dublin, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News